












People	 with	 diabetic	 peripheral	 neuropathy	 (DPN)	 exhibit	 marked	 unsteadiness	during	 gait	 (1),	 increasing	 their	 risk	 of	 falling	 20-fold	 compared	 to	 their	matched	counterpart	 without	 diabetes	 (2).	 Unsteadiness	 and	 associated	 restrictions	 in	activities	 of	 daily	 living	 predict	 depressive	 symptoms	 in	 patients	 with	 DPN	 (3),	highlighting	the	negative	spiral	between	DPN,	unsteadiness,	falls	and	psychological	distress	(4).	However,	since	unsteadiness	has	been	assessed	by	self-report	in	most	previous	studies,	it	remains	unknown	whether	a	person’s	perception	of	unsteadiness	actually	correlates	with	objective	measures	of	balance	and	gait.	This	study	aimed	to	assess	self-perceived	unsteadiness	in	patients	with	and	without	DPN	as	compared	to	people	 without	 diabetes	 and	 to	 investigate	 how	 self-perceived	 unsteadiness	influences	gait	and	balance	control.		Three	groups	were	investigated:	Patients	with	diabetic	peripheral	neuropathy	(DPN	
group;	neuropathy	disability	score	[NDS]	>6,	vibration	perception	threshold	[VPT]	>25V),	patients	with	diabetes	but	no	neuropathy	(DM	group;	NDS	<3,	VPT	<15V	(5))	and	matched	controls	without	diabetes	(Table	1).	Self-perceived	unsteadiness	was	assessed	using	two	items	from	the	Neuropathy-Specific	Quality	of	Life	Questionnaire	(NeuroQoL)	 asking	 about	 problems	with	 balance	 experienced	 during	walking	 and	standing	(6).	Participants	underwent	gait	analysis	using	a	10-camera	motion	analysis	system	and	force	platforms,	while	walking	at	their	self-selected	speed	in	standardized	footwear.	Separation	between	the	body’s	centre	of	mass	and	the	centre	of	pressure	under	the	feet	in	both	anterior-posterior	and	medio-lateral	planes	were	defined	as	‘dynamic	sway’	as	we	have	previously	described	in	diabetes	patients	(1).		
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The	 DPN	 group	 reported	more	 self-perceived	 unsteadiness	 compared	 to	 DM	 and	control	groups	(P<0.0001).	Body	center	of	mass	movement	was	significantly	altered	in	the	DPN	group	compared	to	the	control	group	(P<0.05;	Table	1).	Gait	velocity	and	step	 length	 were	 significantly	 reduced	 in	 the	 DPN	 group	 compared	 to	 controls	(P<0.0001).	 The	 strongest	 correlations	 with	 participant’s	 self-perceived	unsteadiness	were	with	gait	velocity,	step	length	and	severity	of	DPN	(Table	1).		The	novelty	of	the	present	study	is	in	showing	that	DPN	patients	are	not	only	aware	of	 themselves	 as	 being	 unsteady	 but	 actually	 attempt	 to	 self-regulate	 their	unsteadiness	 by	 walking	 more	 slowly	 and	 taking	 shorter	 steps.	 These	 gait	adjustments	 reduce	 the	 extent	 to	 which	 DPN	 patients	 need	 to	 move	 their	 body	forwards	away	from	their	base	of	support	during	each	step.		Consistent	with	previous	reports	(3),	we	found	that	the	self-perceived	unsteadiness	increases	with	advancing	severity	of	DPN	and	hence,	diabetic	neuropathy	and	self-perceived	 unsteadiness	 seem	 inextricably	 linked	 to	 fall	 risk.	 Interestingly,	 self-perceived	 unsteadiness	 in	 the	 DM	 group	 was	 actually	 no	 different	 from	 that	 of	controls	 without	 diabetes.	 These	 findings	 are	 consistent	 with	 our	 gait	 laboratory	study	showing	that	significant	unsteadiness	was	only	present	in	patients	with	DPN	(1).	Therefore,	participant’s	perception	of	unsteadiness	appears	to	match	that	of	gait	laboratory	measurements	of	balance	impairment.	Indeed,	we	show	almost	identical	group	mean	 values	 for	maximum	medio-lateral	 dynamic	 sway,	 a	 key	 indicator	 of	balance	impairments,	as	we	did	in	a	previous	study	with	the	same	group	allocations	(DPN,	DM	and	Controls)	during	level	walking	(1).	The	present	study	has	also	found	a	significant	 correlation	 between	 the	 anterior-posterior	 dynamic	 sway	 and	 self-
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	 Control	 DM	 DPN	 P	value	 Spearman’s	coefficient	 P	Value	
Demographics	 	 	 	 	 	 	Age	(years)	 56	(2)	 56	(2)	 62	(3)	 0.227	 -	 -	
Body	mass	
(kg)	 79	(3)	 78	(3)	 91	(4)
+	 0.016	 -	 -	Height	(m)	 1.72	(0.02)	 1.7	(0.02)	 1.7	(0.03)	 0.687	 -	 -	
Peripheral	
neuropathy	 	 	 	 	 	 	
NDS	
(score/10)	
1	(1)	 1	(0)	 8	(1)+,	ǂ	 0.0002	 0.66**	 0.0001	
VPT	(V)	 6	(3)	 8	(1)	 28	(2)+,	ǂ	 0.0001	 0.61**	 0.0001	
Self-perceived	
unsteadiness	 	 	 	 	 	 	
Walking	
(score/5)	
1.2	(0.3)	 1.3	(0.7)	 2.3	(0.9)+,	ǂ	 0.0002	 -	 -	
Standing	
(score/5)	
1.3	(0.7)	 1.1	(0.4)	 2.4	(1)+,	ǂ	 0.0001	 -	 -	
Dynamic	sway	 	 	 	 	
Anterior	Max	
(cm)	
31.3	(2)	 25.5	(0.9)+	 24.7	(1.9)	 0.132	 -0.31*	 0.029	Posterior	Max	(cm)	 20.2	(2.3)	 18.7	(0.8)	 16.1	(2.1)	 0.425	 0.36*	 0.010	M-L	Max	(cm)	 7.9	(0.8)	 8	(1.1)	 9.8	(0.8)	 0.288	 0.22	 0.068	M-L	range	(cm)	 3.1	(0.4)	 2.5	(0.3)	 4	(0.6)	 0.160	 0.11	 0.44	
Temporal-spatial	gait	
characteristics	 	 	 	 	 	
Gait	velocity	
(m/s)	 1.49	(0.04)	 1.45	(0.05)	 1.17	(0.06)
+	,	ǂ	 0.0002	 -0.57**	 0.0001	
Step	length	
(cm)	 77.2	(1.7)	 72.7	(1.7)	 64.4	(2.9)
+	 0.004	 -0.58**	 0.0001	Step	width	(cm)	 11.4	(0.7)	 11.3	(0.7)	 12.7	(0.6)	 0.234	 0.10	 0.49	
Center	of	
mass	 	 	 	 	 	 	M-L	Range	(cm)	 3.8	(0.3)	 4	(0.4)	 4.6	(0.4)	 0.302	 0.11	 0.466	
A-P	Range	
(cm)	 94.1	(1.7)	 91.7	(1.6)	 82.6	(3.2)
+	 0.013	 -0.47**	 0.0010	Group	comparisons:	values	are	means	(SD);	significant	differences	in	the	DPN	group	compared	to	the	control	and	DM	groups	are	indicated	by	+	and	ǂ,	respectively.	P	values	
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shown	 are	 for	 the	 outcome	 of	 the	 non-parametric	 one-way	 analysis	 of	 variance.	Controls	(n=19):	are	people	without	diabetes	or	peripheral	neuropathy;	DM:	(n=15):	are	 people	 with	 diabetes	 but	 without	 neuropathy;	 DPN:	 (n=15):	 are	 people	 with	moderate-severe	diabetic	peripheral	neuropathy.	NDS:	neuropathy	disability	score;	VPT:	 vibration	 perception	 threshold;	 M-L:	 medio-lateral;	 A-P:	 anterior-posterior.	Correlations:		Correlation	between	participant’s	self-perceived	unsteadiness	and	key	neuropathy	 and	 gait	 variables	 for	 all	 groups	 combined	 (n=49).	 *	 and	 **	 indicate	significance	at	P<0.05	and	P<0.01	levels,	respectively.								
